Request that the FDA determine and declare that Propranolol Hydrochloride Tablets 120 mg and 160 mg is suitable for submission in an Abbreviated New Drug Application (ANDA) | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

Open for Comments

FDA-2026-P-7228

Request that the FDA determine and declare that Propranolol Hydrochloride Tablets 120 mg and 160 mg is suitable for submission in an Abbreviated New Drug Application (ANDA)

Documents

Comments

Description

OPEN

Key Dates

Comment Period OpensJun 29, 2026

Documents

Type	Title	Posted	Comments	Status
Other	Suitability Petition Amendment from Senores Pharmaceuticals, Inc.	Jul 27, 2026	--

Keywords

CDER

Suitability Petition

Senores Pharmaceuticals, Inc

determine and declare that

Propranolol Hydrochloride Tablets

120 mg and 160 mg is suitable for

submission in an

Abbreviated New Drug Application (ANDA)

Data from Regulations.gov